Clinical Trial Recruitment Industry To Grow Up As Of Increasing Number Of Therapeutics Being Studied For The Management And Cure Of Rare Diseases

 

 

Clinical trial recruitment industry data book covers clinical trial site management organization, clinical trial patient recruitment and clinical trial support services market.

Global clinical trial recruitment industry data book is a collection of market sizing information & forecasts, legal authorizations, payout/reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

The global Clinical Trial Recruitment Industry generated over USD 15.7 billion in 2021 and is projected to expand at a CAGR of around 6.1% during the forecast period.

Clinical Trial Patient Recruitment Market Analysis & Forecast

The global patient recruitment market generated over USD 780 million revenue in 2021 and is projected to expand at a CAGR of around 8.0% during the forecast period to reach USD 1.6 billion by 2030.The growing number of clinical studies globally is one of the key reasons supporting the demand for clinical trial patient recruitment. Moreover, there is a growing amount of funding for clinical research, and the wide adoption of digital technologies in clinical research further supports the market's growth. In addition, digital technology has made it possible to develop a strong patient recruiting strategy, whereas historically drug manufacturers have utilized TV commercials, radio, and print media for patient recruitment. With the help of digital capabilities and technological innovations, traditional engagement can be enhanced with digital engagement. Hospitals and caregivers can continuously monitor & track patient health remotely; patients do not have to visit hospitals physically. As a result, the outcome of the treatment can be tracked easily, contributing to data collection, analysis, and data-driven decision-making.

Clinical trial patient recruitment providers offer valuable assistance to pharmaceutical companies by streamlining the recruitment process and improving patient retention throughout the clinical trial. As a result, many companies are now outsourcing patient recruitment services to these specialized organizations. This trend creates opportunities for market players in the patient recruitment services sector to expand their global presence and meet the growing demand for efficient and effective patient recruitment strategies in clinical trials.

North America held the largest share of 50.1% in 2022. The market is expected to grow significantly, driven by the region's substantial number of ongoing clinical trials. Asia Pacific (APAC) region is expected to grow with a 9.1% CAGR across the forecast period. There is an increase in offshoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is due to the low cost of trials and a wide patient pool, further supporting regional growth.

Order Free Sample Copy of Clinical Trial Recruitment Industry Data Book, published by Grand View Research

Clinical Trial Site Management Organization Market Analysis & Forecast

The global clinical trials site management organizations market size was valued at USD 4,792.5 million in 2021 and is anticipated to expand at a CAGR of 5.8% from 2022 to 2030. The market has noticed critical growth on account of the rising R&D investments by pharmaceutical companies owing to the high burden of chronic and infectious diseases. Apart from this, the COVID-19 pandemic has contributed significantly to the demand for clinical trials; as of 12th April 2022, over 4,645 studies for COVID-19 were in the active stage. Such factors are promoting the market growth.

Clinical research sites have historically been a highly fragmented sector, consisting largely of part-time physician practices and small stand-alone companies. Consolidation has been occurring at an unprecedented rate, with sites coming together under common ownership or administration to operate as a single network. There are two business models in the clinical research industry for clinical trial sites - Free-standing research sites or dedicated research centers, and physician-affiliated clinical trial sites.

Asia Pacific, the market for clinical trial site management organizations is projected to witness a CAGR of 6.8% during the forecast period. In Asia Pacific, the market for clinical trial site management organizations is projected to witness a CAGR of 6.8% during the forecast period. The region has become a hotspot for conducting clinical trials on account of the ease of regulatory compliance, cheap study costs, a growing patient population, and the existence of a few elite clinical institutions functioning as sites.

Clinical Trial Support Services Market Analysis & Forecast

The global clinical trials support services market was valued at USD 10,124 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The global market is projected to expand rapidly due to the rising demand for trials in emerging economies, rising R&D investment, and an increasing number of contract research organizations (CROs). The pharmaceutical firms’ (R&D) venture has been steadily increasing every year, largely due to patent expirations. An ordinary patent terminates after 20 years; in the pharmaceutical area, there is an arrangement that provides for the entry of a generic version of the medication into the market following a time of 10 years. Thus, firms are boosting their R&D interests to speed the advancement of drugs, subsequently extending the whole market.

The clinical trial sector underwent significant changes in 2021. With the introduction of COVID-19 vaccines, numerous clinical trials that had been halted due to the pandemic were re-initiated. In the first quarter of 2021, around 44% more clinical trials commenced compared to the first quarter of 2020. Although in-person clinical trials were once again viable, adoption of new technologies remained high, with 74% of sponsors adopting remote monitoring and 77% of sites using eRegulatory software.

North America dominated the global market in 2022 with the largest share of 50.1%, as most of the pharmaceutical businesses located in the U.S. perform a majority of their business in this region. This market is likely to grow due to the high number of clinical trials being conducted in the region. Asia Pacific is anticipated to be the fastest-growing at CAGR 8.5% regional market during the forecast period. Factors driving the APAC market include a developing patient population, simplicity of administrative compliance, minimal expense of conducting studies, and the presence of a couple of top clinical organizations acting at sites.

Go through the table of content of Clinical Trial Recruitment Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Key players operating in the clinical trial recruitment industry are –

• Antidote
• Clara Health
• Clariness
• BBK Worldwide
• Worldwide Clinical Trials
• Clinical Site Services (CCSi)
• IQVIA
• PPD Inc
• Veristat
• Elligo Health Research
• Charles River Laboratories Inc.
• Eurofins Scientific SE
• Syneos Health Inc.
• The Pharmaceutical Product Development LLC
• Icon PLC
• WuXi AppTec
• LabCorp
• Alcura
• Parexel International
• Clinedge
• WCG
• ClinChoice
• Access Clinical Research
• FOMAT Medical Research INC.
• SGS
• KV Clinical
• SMO-Pharmina
• Xylem Clinical Research
• Aurum Clinical Research

 

Male Infertility Industry Is Expected To Grow Up Due To Increasing Demand For Assisted Reproductive Technology (ART)

 

 

Global male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

The global male infertility industry was valued at USD 4.03 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.95% from 2023 to 2030.

Male Infertility Diagnosis Market Analysis & Forecast

The global male infertility diagnosis market size was valued at USD 343.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030. A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes. Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm. It can also lead to erectile dysfunction and decreased libido.

Smoking can also affect the success rate of ARTs, such as IVF. Thus, as a result of the abovementioned factors, the increasing incidence of infertility is expected to help the market grow. Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology.

Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period. The manual method is still widely used for semen analysis in developing economies. However, this method is expected to be replaced by computer-assisted semen analysis in the coming years.

Male Infertility Treatment Market Analysis & Forecast

The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030. High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone.

In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period. Drugs and hormonal therapy are preferred for initial treatment. ART is usually preferred in case treatment with medication fails.

Furthermore, advancements in technology and techniques have significantly improved the success rate of ART procedures. For instance, the use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period.

Order Free Sample Copy of Male Infertility Industry Data Book, published by Grand View Research

Male Infertility Market – Global Industry Segmentation

Male Infertility Diagnosis Market (Revenue, USD Million, 2018 - 2030)
• Technique
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Sperm Penetration Assay
• Others

Male Infertility Treatment Market (Revenue, USD Million, 2018 - 2030)
• Type
• ART and varicocele surgery
• Medication

Male Infertility Industry, By Region (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o India
o Japan
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait

Go through the table of content of Male Infertility Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Male Infertility Industry Data Book Competitive Landscape

Development of innovative technologies, acquisitions, and partnerships or collaborations for the development & commercialization of products are some of the key strategies undertaken by companies to remain competitive in the market. For instance, in October 2022, Endo International plc and the Sexual Medicine Society of North America (SMSNA) reported the launch of Peyronie's Self-Assessment app. Moreover, market players are availing certification from regulatory agencies to strengthen their position in the market.

Key players operating in the male infertility industry are –
• EMD Serono, Inc.
• Endo International plc
• Sanofi
• Bayer Group
• SCSA Diagnostics
• Halotech DNA SL
• Intas Pharmaceuticals Ltd.
• Aytu BioScience, Inc.
• Cadila Pharmaceuticals
• Vitrolife

Surgical Robots Industry Growth Is Attributed Due To The Reduced Risk Of Contamination And Human Error

 

 

Surgical Robots Industry Data Book Covers Orthopedics and Non- Orthopedics Market. The global surgical robots market was valued at USD 3.5 Billion in 2022 and is anticipated to grow at a CAGR of 18.0 % over the forecast period.

Global surgical robots industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a surgical robots statistics e-book.

North America held the largest market share in 2022, owing to the presence of technologically advanced healthcare infrastructure coupled with the increasing adoption of automated surgical equipment. Furthermore, the increasing prevalence of chronic disorders such as diabetes, cardiovascular disease, and cancer is anticipated to drive the demand for advanced and cost-effective surgical robots in the region. According to an article published by Johns Hopkins University, robotic cardiac surgery is a minimally invasive heart surgery performed with robot-controlled tools and instruments. The procedure is generally called Da Vinci surgery based on the name of the manufacturer of the robot.

 

Orthopedics Market Analysis & Forecast

The global orthopedics market was valued at USD 805.7 million in 2022 and is anticipated to grow at a CAGR of 12.8% over the forecast period. The growth is attributed to the increasing prevalence of orthopedic conditions, such as degenerative bone disease, the growing geriatric population, and an increasing number of accidents. According to a study conducted by WHO, around 80% of the geriatric population lives in middle and low-income nations. This is anticipated to create a huge opportunity for key players in the market to expand their presence in emerging nations.

Moreover, the early onset of musculoskeletal problems, mostly caused by a sedentary lifestyle and obesity, is expected to drive market expansion. Musculoskeletal diseases affect around 1.71 billion people globally, according to the Global Burden of Disease in 2021. As a result, an increase in musculoskeletal problems is expected to drive the market over the forecast period. Additionally, growing awareness regarding the availability of innovative items is causing hospitals to improve their technology and services frequently. Furthermore, payment coverage for orthopedic therapies has contributed to the adoption of orthopedic procedures.

Order Free Sample Copy of "Surgical Robots Industry Data Book - Orthopedics and Non- Orthopedics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research

Non-Orthopedics Market Analysis & Forecast

Non-Orthopedic applications of surgical robots include robots for neurology, cardiology, gynecology, urology, and others. The global non-orthopedic market was valued at USD 2.74 billion in 2022 and is anticipated to grow at a CAGR of 19.2% over the forecast period. The growth is attributed to the increasing prevalence of neurological disorders coupled with the rising number of road accidents causing brain injuries. According to the International Brain Injury Association, around one million traumatic brain injuries are treated in the United States every year. Additionally, around 80,000 patients are discharged from hospitals with traumatic brain injury disability.

Furthermore, technological advancements in the field of neurology, urology, and gynecology have eliminated direct human involvement in surgical operations. These devices are reducing the downsides of invasive procedures. Data recorders, HD microscopic cameras, remote navigation systems, motion sensors, transducers, and robotic-controlled catheters are among the most recent advancements. The major market participants are investing much in R&D to develop technologically advanced medical devices. For example, Brain Scientific, Inc. will deliver the next-generation NeuroCap device in March 2021. It is an advanced EEG electrode array that is utilized in clinical and research settings to deliver quick EEGs whenever required. This is anticipated to drive market growth in the coming years.

Furthermore, the increasing prevalence of high blood pressure and diabetes is also contributing to the rising demand for efficient and technologically advanced urology solutions. According to data published by the American Kidney Fund, around 25% of kidney failures are caused due to high blood pressure, and around 38.4% of kidney conditions are caused due to diabetes. The aforementioned factor is anticipated to drive the market demand over the forecast period.

Go through the table of content of Surgical Robots Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Surgical Robots Industry Data Book Competitive Landscape

Increasing demand for surgical robots is increasing competition in the market and, thus, forcing key players to introduce new products of different capabilities in the market. Additionally, it is projected that rising industry consolidation activities, such as acquisitions and mergers by the leading market participants, as well as increasing efforts in R&D of surgical robot applications by key players, are also expected to boost the market share.

Key players operating in the surgical robots industry are –

• Stryker
• Medrobotics
• Smith+Nephew
• TransEnterix Surgical, Inc.
• Renishaw plc.
• Intuitive Surgical
• Medtronic
• THINK Surgical, Inc.
• Zimmer Biomet

Fertility Storage Industry To Grow Due To New Product Approvals And Commercialization Of Home-Based Diagnostic Kits

 

 

Fertility storage industry data book covers egg donation and sperm bank market. The global fertility storage market size was valued at USD 8.74 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 11.51% from 2023 to 2030.

Global fertility storage industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

Egg Donation Market Analysis & Forecast

The global egg donation market size was valued at USD 3.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 17.92% from 2023 to 2030. Some of the driving factors of the market are the increasing demand for donor eggs due to delaying pregnancy by the young generation, rising infertility due to unhealthy habits, and the high success rate of procedures. In the U.S., egg donors are not only compensated for the donation but can also negotiate their compensation amount based on the desirability of their eggs.

According to National Center for Health Statistics, the average age to have a baby in the U.S. increased to 26.3 years in 2016 when compared to 22.7 years in 1980. Furthermore, this age increased to 30.3 years for women with a college degree.

Younger women prefer their own eggs for IVF procedures; however, for women above 40 years of age use of donor eggs increases the success rate of conceiving as the quality and quantity of eggs decline after 40. Delay in pregnancy is a key factor responsible for the declining quality and quantity of own eggs.

Licensed fertility clinics offer counseling to couples having problems conceiving. Based on the severity of their problems, doctors, and specialists plan IVF treatments for couples. Fertility clinics provide state-of-the-art equipment such as micromanipulation, non-invasive Radio Frequency Identification (RFID) tags, and others. This factor is further expected to propel the market growth over the forecast period.

Order Free Sample Copy of “Fertility Storage Industry Data Book - Egg Donation, Sperm Bank Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030”, published by Grand View Research

Sperm Bank Market Analysis & Forecast

The global sperm bank market size was valued at USD 5.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.56% over the forecast period from 2023 to 2030. Innovations in cryopreservation techniques, rising awareness, the emergence of fertility tourism, and increasing access to infertility treatment are the key factors driving the growth. An increase in the risk of miscarriages is also among a few key factors boosting the demand. Moreover, the market is witnessing lucrative growth opportunities owing to the growing acceptance of single-parent or same-sex families in many societies. Growing acceptance of the Lesbian, Gay, Bisexual, and Transgender (LGBT) community is one of the factors driving sperm donations across various countries.

North America dominated the market with a share of 36.9% in 2022. This is majorly attributed to growing prevalence of infertility among the American population. Europe held the second largest share in 2022, mainly due to factors such as lower treatment cost compared to U.S. and Canada and rise in the number of IVF centres. Asia pacific market is expected to witness lucrative growth over the forecast period. Growing demand for ART and low-cost treatment is some of the factors that are expected drive the regional growth. Furthermore, a supportive legislative framework and increase in demand for fertility treatment among Chinese population is another factor boosting the market.

Fertility Storage Market – Global Industry Segmentation

Segmentation For Egg Donation Market (Revenue, USD Million, 2018 - 2030)
• Fertility Centers
• Hospitals and others

Segmentation For Sperm Bank Market (Revenue, USD Million, 2018 - 2030)
• Donor
o Known donor
o Anonymous donor
• Service
o Sperm storage
o Semen analysis
o Genetic consultation

Go through the table of content of Fertility Storage Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Segmentation For Fertility Storage Industry, By Region (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o India
o Japan
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait

Fertility Storage Industry Data Book Competitive Landscape

The market is highly competitive due to the presence of a large number of multinational and local market players. Companies operating in the market are adopting various strategies, such as service launches, facility expansion, and partnerships & collaborations, to gain higher market share.

Key players operating in the fertility storage industry are –
• Cryos International
• New England Cryogenic Center
• European Sperm Bank
• Fairfax Cryobank, Inc
• The London Sperm Bank
• Indian Spermtech
• Reprotech, Llc
• Xytex Corporation
• Cryobank America Llc.
• The Sperm Bank Of California
• Shady Grove Fertility Reproductive Science Center
• Highland Park Ivf Center - Fertility Centers Of Illinois.
• Seattle Reproductive Medicine
• Weill Medical College Of Cornell
• The Center For Assisted Reproduction

Biomarkers Industry Is Anticipated To Boost Due To Rise In The Prevalence Of Cancer And Increasing Investments In Research

 Biomarkers industry data book covers cardiac & cancer biomarkers, non-alcoholic steatohepatitis biomarkers, global neurological biomarkers market.

The global biomarkers markets combine to account for USD 41.62 billion revenue in 2021, which is expected to reach USD 137.76 billion by 2030, growing at a cumulative rate of 14.2% over the forecast period.

Global biomarkers industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

Cardiac Biomarkers Market Analysis & Forecast

The global cardiac biomarkers market was valued at USD 13.98 billion in 2021 and is anticipated to witness growth at a rate of 14.7% over the forecast period. Cardiac biomarkers are witnessing growth owing to factors such as the high prevalence of acute coronary syndrome, technological advancements in cardiac biomarkers, rising demand for point-of-care (POC) cardiac testing kits, and high specificity in the detection of cardiac diseases, especially myocardial infarction.

North America dominated the global market with a share of over 40.0% in 2021. This can be attributed to the developed healthcare system and high adoption of cardiac biomarkers as a tool for diagnosis and predictive diagnosis of conditions. Asia Pacific is expected to expand at a significant rate during the forecast period owing to rising affordability for advanced cardiac tests, modernization in the countries, and increasing disposable income.

Non-alcoholic Steatohepatitis Biomarkers Market Analysis & Forecast

The global NASH biomarkers market was valued at USD 800.6 million in 2021 and is anticipated to witness growth at a rate of 23.6% over the forecast period. Non-alcoholic Steatohepatitis (NASH) biomarkers market is witnessing growth due to the factors such as the rising prevalence of chronic liver diseases which is projected to increase demand for non-invasive diagnostic tools for NASH detection. Moreover, the market growth is propelled owing to the launch of novel diagnostic tests.

North America accounted for the largest market share of 59.53% in 2022 which can be attributed to various factors such as increasing diagnosis rate and the early launch of novel products in this region. Research and development funding for biomarkers is abundant, which supports medication development efforts and fosters business expansion. Europe, the market is expected to witness a lucrative growth rate of 23.51% over the forecast period. The growth of the market is due to the rising disease burden and economic impact of NASH in the region.

Order Free Sample Copy of “Biomarkers Industry Data Book, 2023 - 2030” published by Grand View Research

Cancer Biomarkers Market Analysis & Forecast

The global cancer biomarkers market was valued at USD 19.9 billion in 2021 and is anticipated to witness growth at a rate of 13.9% over the forecast period. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming the positive growth of this market.

Cancer is reported to be the second leading cause of mortality in the U.S. after cardiovascular disorders. Prevalence of breast, prostate, and lung malignancies has increased at a very steep rate with an estimated number of over 1,600 people being affected in the U.S. every year. In 2017, around 200,000 cases of breast cancer have been reported in the U.S.

North America dominated the regional segment followed closely by Europe. High adoption of innovative technology, presence of key pharmaceutical companies, established R&D infrastructure pertaining to the development of novel diagnostic products and increased demand for specific & early diagnostics are the major factors for the aforementioned dominance. Asia Pacific region owing to increasing prevalence of cancer, beneficial environment for clinical trials, and increasing government funding for supporting drug development programs is anticipated to witness lucrative CAGR over the forecast period.

Neurological Biomarkers Market Analysis & Forecast

The global neurological biomarkers market was valued at USD 6.85 billion in 2021 and is anticipated to witness growth at a rate of 12.8% over the forecast period. Some of the major factors expected to drive the market are the increasing prevalence of neurological diseases and growing awareness about the condition among physicians & patients. Furthermore, technological advancements and growing R&D efforts for neurological diseases drugs development are further propelling the overall market.

North America region commanded the highest share of around 41.63% of the market in 2022 and is expected to witness a significant growth rate over the forecast period. Asia Pacific is expected to grow at the highest CAGR from 2023 and 2030. The need for early diagnosis of neurological disorders, which would further aid to reduce treatment costs& mortality, is expected to fuel growth of the market in the region.

Go through the table of content of Biomarkers Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Biomarkers Industry Data Book Competitive Landscape

Biomarkers market has become intensely competitive, and products must successfully clear rigorous assessments, which puts them at a significant clinical advantage over existing products. However, existing brands are constantly renovating and improvising their products to maintain their market position.

Key players operating in the biomarkers industry are –

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Bio-Rad Laboratories
• Epigenomics AG
• Thermo Fisher Scientific, Inc.
• Siemens Healthineers AG
• Johnson & Johnson Services, Inc
• QIAGEN N.V.